| CERS6 — Ceramide Synthase 6 |
|---|
| Protein Name | Ceramide Synthase 6 |
| Gene | [CERS6](/genes/cers6) |
| UniProt ID | [Q3YGD3](https://www.uniprot.org/uniprot/Q3YGD3) |
| Chromosomal Location | 2q33.3 |
| Molecular Weight | ~45 kDa (384 amino acids) |
| Subcellular Localization | Endoplasmic reticulum membrane |
| Protein Family | Ceramide synthase family (Lag1 family) |
| EC Number | 2.3.1.24 |
CERS6 (Ceramide Synthase 6) is a critical enzyme in the de novo biosynthesis of ceramides, catalyzing the N-acylation of sphingoid bases to produce ceramide lipids. As the primary enzyme generating C14- and C16-ceramides—the most abundant ceramide species in mammalian cells—CERS6 plays a fundamental role in maintaining cellular membrane composition, regulating lipid raft dynamics, and mediating stress-responsive signaling pathways.
In the nervous system, CERS6 is essential for neuronal health, synaptic function, and myelin maintenance. Importantly, dysregulated CERS6 activity has been strongly implicated in the pathogenesis of Alzheimer's disease (AD) and Parkinson's disease (PD), where ceramide metabolism is profoundly altered. The enzyme's role in generating amyloid-promoting lipid environments and contributing to neuronal death pathways has made it an emerging therapeutic target for neurodegeneration .
¶ Domain Architecture and Catalytic Mechanism
CERS6 is a tail-anchored ER membrane protein with a characteristic domain organization:
- N-terminal regulatory domain: Contains the Lag1 ( longevity assurance gene 1) motif essential for catalytic activity
- Transmembrane regions: Six predicted transmembrane helices anchor the protein in the ER membrane
- C-terminal catalytic domain: Houses the active site for acyl-CoA binding and ceramide synthesis
The Lag1 motif, conserved across all six mammalian ceramide synthases (CERS1-6), contains a critical HXXHH histidine cluster required for catalysis. Structural studies have revealed that CERS6 forms homodimers or heterodimers with other CerS isoforms, and dimerization is essential for functional activity .
CERS6 exhibits distinctive substrate specificity:
| Property |
Specification |
| Preferred acyl-CoA substrates |
C14 (myristoyl-CoA), C16 (palmitoyl-CoA) |
| Primary products |
C14-ceramide, C16-ceramide |
| Km for palmitoyl-CoA |
~5 μM |
| Km for sphinganine |
~10 μM |
| pH optimum |
7.0-7.5 |
| Inhibitors |
Fumonisin B1, L-cycloserine, avasinone |
The enzyme catalyzes the following reaction:
sphinganine + acyl-CoA → dihydroceramide + CoA
dihydroceramide → ceramide (via desaturation)
CERS6 activity is regulated at multiple levels:
- Transcriptional regulation: SREBP (sterol regulatory element-binding protein) activates CERS6 transcription in response to low cholesterol; PPARγ agonists also increase expression
- Post-translational modification: Phosphorylation can modulate activity; oxidative stress may inhibit function
- Protein-protein interactions: Interaction with other CerS isoforms affects substrate specificity and product distribution
- Substrate availability: Cellular pools of sphingoid bases and acyl-CoAs limit reaction rate
- Product feedback: Accumulated ceramides can feedback-inhibit CerS activity
¶ Membrane Composition and Lipid Raft Dynamics
CERS6-generated ceramides are essential for maintaining cellular membrane properties:
Ceramide molecules spontaneously cluster to form lipid rafts—dynamic, ordered membrane microdomains enriched in cholesterol and sphingolipids:
- Raft initiation: Ceramide generation triggers raft nucleation by promoting ordered packing
- Raft expansion: C16-ceramide stabilizes raft domains and increases their size
- Raft function: Lipid rafts concentrate signaling molecules, including receptors and下游 effectors
- Neuronal rafts: Synaptic membranes are particularly enriched in lipid rafts, which regulate neurotransmitter release and receptor trafficking
CERS6 activity influences vesicular trafficking pathways:
- ER-Golgi transport: Ceramide availability affects cargo packaging and vesicle formation
- Endosomal sorting: Ceramide content influences endosomal membrane composition
- Autophagosome formation: Ceramide generation is required for autophagosome biogenesis
CERS6 occupies a central position in sphingolipid biosynthesis:
flowchart TD
A["Palmitate + Serine"] --> B["Sphinganine"]
B --> C["Dihydroceramide"]
C --> D{"CERS6"}
D -->|"C14-acyl-CoA"| E["C14-Ceramide"]
D -->|"C16-acyl-CoA"| F["C16-Ceramide"]
E --> G["Sphingomyelin"]
E --> H["Glucosylceramide"]
E --> I["Gangliosides"]
F --> G
F --> H
F --> I
J["Degradation"] --> K["Sphingosine"]
K --> L["S1P"]
classDef blue fill:#e1f5fe,stroke:#0277bd
classDef green fill:#c8e6c9,stroke:#2e7d32
classDef orange fill:#fff3e0,stroke:#ef6c00
class A,B,C blue
class D green
class E,F,G,H,I orange
class J,K,L blue
Beyond structural roles, ceramides function as bioactive signaling molecules:
¶ Apoptosis and Cell Survival
CERS6-generated ceramides mediate stress-induced apoptosis:
- Mitochondrial pathway: Ceramide directly induces mitochondrial outer membrane permeabilization
- Ceramide-activated protein phosphatases: C1- and C2-ceramide activate PP1 and PP2A
- JNK activation: Ceramide stimulates c-Jun N-terminal kinase signaling
- PKC inhibition: Certain ceramide species inhibit conventional PKC isoforms
Ceramide serves as a pro-inflammatory lipid mediator:
- NF-κB activation: Ceramide stimulates canonical NF-κB signaling
- Inflammasome assembly: Ceramide promotes NLRP3 inflammasome formation
- Cytokine production: Ceramide induces TNF-α, IL-1β, and IL-6 expression
CERS6 links lipid metabolism to insulin signaling:
- Akt inhibition: Ceramide accumulation blocks Akt phosphorylation and insulin signaling
- AMPK activation: Ceramide stimulates AMP-activated protein kinase
- Lipid droplet formation: Ceramide promotes lipid droplet accumulation in hepatocytes
CERS6 exhibits region-specific expression in the brain:
| Brain Region |
Expression Level |
Primary Cell Types |
| Cerebral cortex |
High |
Pyramidal neurons, interneurons |
| Hippocampus |
High |
CA1/CA3 pyramidal cells, dentate gyrus granule cells |
| Cerebellum |
High |
Purkinje cells |
| Substantia nigra |
High |
Dopaminergic neurons |
| Brainstem |
Moderate |
Various neuronal populations |
| White matter |
Moderate |
Oligodendrocytes |
Within the nervous system, CERS6 is expressed in multiple cell types:
- Somatic expression: CERS6 localizes to the ER in neuronal cell bodies
- Dendritic localization: Present in dendritic ER, influencing dendritic membrane composition
- Synaptic terminals: Detected in presynaptic terminals, regulating neurotransmitter release
- Axonal compartments: Enriched in axonal membranes, particularly at nodes of Ranvier
- Glial expression: Astrocytes express CERS6 at levels comparable to neurons
- Metabolic support: Astrocytic CerS6 contributes to lipid homeostasis for neurons
- Inflammatory responses: CERS6 mediates astrocyte activation in response to injury
- Myelin production: Critical for generating myelin sphingolipids
- Expression level: High expression in mature oligodendrocytes
- Myelin stability: Ceramide composition affects myelin membrane stability
CERS6 is strongly implicated in AD pathogenesis through multiple mechanisms:
CERS6-generated ceramides promote amyloidogenic APP processing:
- Lipid raft enrichment: Ceramide accumulation increases lipid raft formation in neurons, concentrating APP and BACE1
- BACE1 activation: Ceramide directly stimulates β-secretase activity
- APP trafficking: Altered ceramide affects APP passage through the secretory pathway
- Amyloid plaque association: C16-ceramide is enriched in AD brain regions with amyloid deposits
The correlation between elevated C16-ceramide and increased amyloid burden in AD brains has been consistently documented .
Ceramide contributes to tau dysregulation:
- Phosphatase activation: Ceramide activates protein phosphatases that dephosphorylate tau
- Kinase stimulation: Ceramide stimulates tau-phosphorylating kinases (GSK3β, CDK5)
- Aggregation promotion: Ceramide directly facilitates tau filament formation
- Tau secretion: Ceramide influences tau release via exosomes
CERS6 activity disrupts synaptic integrity:
- Synaptic membrane composition: Altered ceramide affects synaptic membrane fluidity
- SNARE complex function: Ceramide impairs SNARE assembly and vesicle fusion
- Receptor trafficking: Ceramide disrupts AMPA and NMDA receptor cycling
- Synaptic plasticity: LTP and LTD are impaired by ceramide accumulation
Ceramide accumulation triggers neurodegeneration:
- Mitochondrial dysfunction: Ceramide induces mitochondrial permeability transition
- Oxidative stress: Ceramide promotes reactive oxygen species generation
- ER stress: Ceramide activates unfolded protein response pathways
- Autophagy dysregulation: Ceramide both stimulates and disrupts autophagic flux
Emerging evidence links CERS6 to PD pathogenesis:
CERS6 is highly expressed in substantia nigra dopaminergic neurons, which are selectively vulnerable in PD:
- Metabolic stress: High CERS6 expression may make these neurons susceptible to ceramide accumulation
- α-Synuclein interaction: Ceramide promotes α-synuclein aggregation and oligomerization
- Mitochondrial vulnerability: Ceramide-induced mitochondrial dysfunction particularly affects dopaminergic neurons
CERS6 contributes to mitochondrial pathology:
- Complex I inhibition: Ceramide accumulation impairs mitochondrial complex I activity
- Dynamin regulation: Ceramide affects DRP1-mediated mitochondrial fission
- Mitophagy disruption: Ceramide impairs PINK1/Parkin-mediated mitophagy
CERS6 dysregulation contributes to ER stress in PD models:
- Unfolded protein response: Ceramide accumulation activates UPR signaling
- Calcium dysregulation: Ceramide disrupts ER calcium homeostasis
- Apoptotic signaling: ER stress converges with ceramide-mediated apoptosis
CERS6 has been implicated in motor neuron disease:
- Motor neuron expression: High CERS6 in spinal motor neurons
- Protein aggregation: Ceramide promotes misfolded protein aggregation
- Energy metabolism: Ceramide disrupts metabolic homeostasis in motor neurons
¶ Multiple Sclerosis and Demyelination
While not primarily neurodegenerative, CERS6 affects myelin maintenance:
- Oligodendrocyte function: CERS6 generates myelin-enriched ceramides
- Demyelination: Ceramide accumulation contributes to myelin breakdown
- Remyelination failure: Dysregulated ceramide impairs oligodendrocyte progenitor differentiation
CERS6 represents a compelling therapeutic target for neurodegeneration:
- Disease modification: Modulating ceramide production addresses upstream pathological drivers
- Amyloid-independent effects: Benefits extend beyond amyloid reduction to include neuroprotection
- Accessibility: Small molecules can potentially access the CNS
- Biomarker potential: CSF ceramide levels may serve as pharmacodynamic markers
CERS6 inhibitors reduce pathogenic ceramide accumulation:
| Compound |
Specificity |
Development Status |
Key Findings |
| Fumonisin B1 |
Pan-CerS |
Preclinical |
Reduces amyloid pathology in AD models |
| L-cycloserine |
Pan-CerS |
Preclinical |
Blocks ceramide-induced apoptosis |
| Sonepcizumab |
Anti-ceramide Ab |
Clinical (cancer) |
Investigational for neurodegeneration |
| ABC294640 |
CERS2/CERS4 |
Preclinical |
Modulates sphingolipid balance |
Clinical development of CerS inhibitors for CNS disorders remains in early stages .
Limiting substrate availability reduces ceramide production:
- Fatty acid synthase inhibitors: Reduce available palmitate for ceramide synthesis
- Dietary interventions: Lower dietary saturated fat intake
- Metabolic modulators: Improve systemic lipid metabolism
Alternative approaches enhance ceramide clearance:
- Glucosylceramide synthase inhibitors: Redirect ceramide to less toxic metabolites
- Acid ceramidase activators: Increase ceramide catabolism
- S1P receptor modulators: Shift balance toward pro-survival signaling
¶ Challenges and Considerations
- BBB penetration: Achieving sufficient CNS exposure with small molecules
- Target specificity: Developing CERS6-selective inhibitors vs. pan-CerS inhibitors
- Physiological functions: Avoiding disruption of essential ceramide signaling
- Biomarker development: Identifying patient subsets most likely to benefit
- Treatment timing: Determining optimal intervention window in disease course
CERS6 intersects with APP metabolism:
- Raft-mediated processing: Ceramide promotes amyloidogenic BACE1 cleavage
- APP trafficking: Ceramide affects APP passage through secretory pathway
- γ-secretase modulation: Ceramide influences final APP cleavage
Bidirectional relationship with tau:
- Tau phosphorylation: Ceramide stimulates tau-phosphorylating kinases
- Tau aggregation: Ceramide directly promotes tau filament formation
- Tau secretion: Ceramide modulates tau release in exosomes
CERS6 contributes to inflammatory processes:
- Microglial activation: Ceramide promotes microglial inflammatory responses
- Astrocyte reactivity: Ceramide induces astrocyte activation
- Peripheral immune infiltration: Ceramide affects BBB permeability
CERS6 interacts with mitochondrial pathways:
- Mitophagy regulation: Ceramide modulates PINK1/Parkin pathway
- Mitochondrial dynamics: Ceramide affects fission/fusion balance
- Apoptotic signaling: Ceramide is a key mediator of intrinsic apoptosis
CERS6 connects to numerous NeuroWiki pages:
¶ Proteins and Genes